A Trial of Local Anaesthesia Versus Local Anaesthesia and Conscious Sedation for Hernioplasty

NCT ID: NCT02444260

Last Updated: 2015-05-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-12-31

Study Completion Date

2016-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this RCT is to compare patient outcomes of inguinal hernioplasty under Local Anaesthesia alone versus Local Anaesthesia and Conscious Sedation

Specific study objectives are to determine the effect of conscious sedation on:

(i) patient satisfaction (ii) postoperative pain (iii) time to discharge (iv) intraoperative complications (v) postoperative functional status (vi) short-term postoperative complications (vii) long-term postoperative complications

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inguinal Hernia Anesthesia, Local Conscious Sedation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intravenous Normal Saline

Intravenous Normal Saline plus Lignocaine HCl (1%) - administered by wound infiltration to a maximum dose of 4.5mg/kg ; Bupivocaine HCl (0.25%) - administered by wound infiltration to a maximum dose of 2 mg/kg plus i

Group Type SHAM_COMPARATOR

Intravenous Normal Saline

Intervention Type DRUG

Intravenous normal saline will be infused by non-blinded anaesthetist

Bupivocaine

Intervention Type DRUG

Bupivcaine 0.25% solution administered by wound infiltration to a maximum dose of 2 mg/kg

Lignocaine HCl

Intervention Type DRUG

Lignocaine !% solution administered by wound infiltration to a maximum dose of 4.5mg/kg

Midazolam

Lignocaine HCl (1%) - administered by wound infiltration to a maximum dose of 4.5mg/kg Bupivocaine HCl (0.25%) - administered by wound infiltration to a maximum dose of 2 mg/kg plus Midazolam - administered intravenously. 1 mg given stat. Titrated by 1 mg to a maximum dose of 10 mg.

Group Type ACTIVE_COMPARATOR

Midazolam

Intervention Type DRUG

Midazolam will administered intravenously. 1 mg given stat. Titrated by 1 mg to a maximum dose of 10 mg. Additional sedation will be given to achieve and maintain a score of 2-3 on the Ramsay sedation scale during the procedure, up to the maximum dose of 10mg.

Bupivocaine

Intervention Type DRUG

Bupivcaine 0.25% solution administered by wound infiltration to a maximum dose of 2 mg/kg

Lignocaine HCl

Intervention Type DRUG

Lignocaine !% solution administered by wound infiltration to a maximum dose of 4.5mg/kg

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Midazolam

Midazolam will administered intravenously. 1 mg given stat. Titrated by 1 mg to a maximum dose of 10 mg. Additional sedation will be given to achieve and maintain a score of 2-3 on the Ramsay sedation scale during the procedure, up to the maximum dose of 10mg.

Intervention Type DRUG

Intravenous Normal Saline

Intravenous normal saline will be infused by non-blinded anaesthetist

Intervention Type DRUG

Bupivocaine

Bupivcaine 0.25% solution administered by wound infiltration to a maximum dose of 2 mg/kg

Intervention Type DRUG

Lignocaine HCl

Lignocaine !% solution administered by wound infiltration to a maximum dose of 4.5mg/kg

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Dormicum 0.9% sodium chloride solution Marcaine xylocaine

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Reducible inguinal hernia

Exclusion Criteria

* Renal, hepatic, respiratory, cardiovascular, neurologic or psychiatric disease
* Body mass index \< 18.5 kg/m2 or \> 30 kg/m2
* Recurrent inguinal hernias
* Bilateral inguinal hernias
* Large inguinoscrotal hernias
* Incarcerated hernia
* Allergies to local anaesthetic and sedative agents
* Pregnancy
* Lactation
* Chronic pain syndromes
* Anxiety disorders
* Marijuana use
* Long term use of opioid or sedative agents
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The University of The West Indies

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of the West Indies, mona

Kingston, Please Select, Jamaica

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Jamaica

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pierre Leake, DM

Role: CONTACT

Marvin Reid, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Pierre Leake, DM

Role: primary

References

Explore related publications, articles, or registry entries linked to this study.

Leake PA, Toppin PJ, Reid M, Plummer JM, Roberts PO, Harding-Goldson H, McFarlane ME. Local Anesthesia Versus Local Anesthesia and Conscious Sedation for Inguinal Hernioplasty: Protocol of a Randomized Controlled Trial. JMIR Res Protoc. 2017 Feb 7;6(2):e20. doi: 10.2196/resprot.6754.

Reference Type DERIVED
PMID: 28174148 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ECP342,12/13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Inhaled Sedation in Critically Ill Patients
NCT07000526 RECRUITING PHASE4
Sevoflurane Induced Emergence Agitation
NCT02022488 COMPLETED PHASE4